Beata J. Mossakowska

Warsaw, MZ 02781, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

DNA Hypomethylation of MIR21 Drives Hsa-miR-21-5p Expression in High-Grade Meningiomas and Reshapes Transcriptomic Signatures of Oncogenic Pathways and Intercellular Communication.

DNA Hypomethylation of MIR21 Drives Hsa-miR-21-5p Expression in High-Grade Meningiomas and Reshapes Transcriptomic Signatures of Oncogenic Pathways and Intercellular Communication.

Journal: International journal of molecular sciences

Published: April 12, 2026

USP8, USP48, BRAF and TP53 mutations in crooke cell adenoma.

USP8, USP48, BRAF and TP53 mutations in crooke cell adenoma.

Journal: Pituitary

Published: August 07, 2025

High level of aneuploidy and recurrent loss of chromosome 11 as relevant features of somatotroph pituitary tumors.

High level of aneuploidy and recurrent loss of chromosome 11 as relevant features of somatotroph pituitary tumors.

Journal: Journal of translational medicine

Published: July 04, 2024

DNA hypomethylation-related expression of hsa-miR-184 contributes to invasive growth of gonadotroph neuroendocrine pituitary tumors.

DNA hypomethylation-related expression of hsa-miR-184 contributes to invasive growth of gonadotroph neuroendocrine pituitary tumors.

Journal: Journal of neuroendocrinology

Published: May 15, 2024

Relevance of mutations in protein deubiquitinases genes and TP53 in corticotroph pituitary tumors.

Relevance of mutations in protein deubiquitinases genes and TP53 in corticotroph pituitary tumors.

Journal: Frontiers in endocrinology

Published: September 26, 2023

Epigenetic Downregulation of Hsa-miR-193b-3p Increases Cyclin D1 Expression Level and Cell Proliferation in Human Meningiomas.

Epigenetic Downregulation of Hsa-miR-193b-3p Increases Cyclin D1 Expression Level and Cell Proliferation in Human Meningiomas.

Journal: International journal of molecular sciences

Published: July 20, 2023

DNA Methylation Pattern in Somatotroph Pituitary Neuroendocrine Tumors.

DNA Methylation Pattern in Somatotroph Pituitary Neuroendocrine Tumors.

Journal: Neuroendocrinology

Published: May 25, 2023

The expression of glucocorticoid and mineralocorticoid receptors in pituitary tumors causing Cushing's disease and silent corticotroph tumors.

The expression of glucocorticoid and mineralocorticoid receptors in pituitary tumors causing Cushing's disease and silent corticotroph tumors.

Journal: Frontiers in endocrinology

Published: December 15, 2022

Transcriptomic Classification of Pituitary Neuroendocrine Tumors Causing Acromegaly.

Transcriptomic Classification of Pituitary Neuroendocrine Tumors Causing Acromegaly.

Journal: Cells

Published: October 19, 2022

Possible Mechanisms of Resistance Development to Photodynamic Therapy (PDT) In Vulvar Cancer Cells.

Possible Mechanisms of Resistance Development to Photodynamic Therapy (PDT) In Vulvar Cancer Cells.

Journal: International journal of molecular sciences

Published: October 11, 2022

The Expression of Cell Cycle-Related Genes in USP8-Mutated Corticotroph Neuroendocrine Pituitary Tumors and Their Possible Role in Cell Cycle-Targeting Treatment.

The Expression of Cell Cycle-Related Genes in USP8-Mutated Corticotroph Neuroendocrine Pituitary Tumors and Their Possible Role in Cell Cycle-Targeting Treatment.

Journal: Cancers

Published: September 20, 2022

Mechanisms of Resistance to Photodynamic Therapy (PDT) in Vulvar Cancer.

Mechanisms of Resistance to Photodynamic Therapy (PDT) in Vulvar Cancer.

Journal: International journal of molecular sciences

Published: March 01, 2022

Showing 1-12 of 13

Last Updated: 09/26/2026